Published 2023-01-03
Keywords
- Schistosomiasis mansoni,
- Liver,
- Comorbidities,
- Lipids,
- Stereology
How to Cite
Copyright (c) 2022 Brazilian Journal of Health and Biomedical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abstract
Introduction: Human and animal studies have shown that schistosomiasis protects against metabolic diseases such as dyslipidemia, atherosclerosis and diabetes. Objectives: However, less is known about the effects of a high-fat diet on hepatic architecture, formation and composition of granulomas in acute schistosomiasis mansoni. Methods: Male C57BL/6 mice fed high-fat (60% fat) chow or standard (10% fat) chow for 13 weeks were infected with 80 Schistosoma mansoni cercariae. The mice were assigned into four groups: uninfected fed standard (SC), high-fat chow (HFC), infected fed standard (ISC) and high-fat chow (IHFC). Blood lipid concentrations (cholesterol, triglycerides, LDL, VLDL, HDL), oral glucose tolerance test, body mass gain, liver mass and intestinal parasite egg counting (oogram), cellular composition, percentage of inflammatory infiltrates and morphometric features (area and perimeter) of liver granulomas were measured. The volumetric density of hepatocytes, steatosis, sinusoids, necrosis and hepatic fibrosis were estimated by using stereology. Results: IHFC mice showed lower blood lipid levels, biometrics, improved glucose tolerance and less steatosis compared to control mice (HFC). The IHFC group showed larger granulomas, predominance of polymorphonuclear cells and rich inflammatory infiltration, binucleated hepatocytes and histopathological changes more severe than ISC. Conclusion: Although acute schistosomiasis reduces the effects of a high-fat diet on the host’s metabolism, it induces damage to liver architecture.
Metrics
References
- Colley DG, Bustinduy AL, Secor WE, et al. Human schistosomiasis. Lancet. 2014;383(9936):2253–64.
- McManus DP, Dunne DW, Sacko M, et al. Schistosomiasis. Nat Rev Dis Prim. 2018;4(1):1-13.
- Katz N. Inquérito Nacional de Prevalência da Esquistossomose mansoni e Geo-helmintoses Fiocruz. [Internet]. 2018; 76. Acesso em 15 de dezembro de 2020. Disponível em: http://www2.datasus.gov.br/datasus/index.php?area=0208.
- Hams E, Aviello G, Fallon PG. The Schistosoma granuloma: Friend or foe? Front Immunol. 2013;4(APR):1–8.
- Schwartz C, Fallon PG. Schistosoma “Eggs-Iting” the Host: Granuloma Formation and Egg Excretion. Front immunol. 2018;9:2492.
- Andrade ZA. Schistosomiasis and liver fibrosis. Parasite Immunol. 2009;31(11):656–63.
- Andrade ZA. Schistosomiasis and hepatic fibrosis regression. Acta Trop. 2008;108(2–3):79–82.
- Lenzi H. L, Kimmel E, Schechtman H, et al. Histoarchitecture of schistosomal granuloma development and involution: morphogenetic and biomechanical approaches. Memorias do Instituto Oswaldo Cruz. 1998;93(Suppl. 1):141-151.
- Alves CC, Araujo N, Cassali GD, et al. Parasitological, Pathological and Immunological Parameters Associated To Schistosoma mansoni Infection and Reinfection in Balb/C and C57Bl-6 Mice. J Parasitol. 2016;102(3):336–41.
- Neves RH, Alencar ACMB, Aguila MB, et al. Hepatic stereology of schistosomiasis mansoni infected-mice fed a high-fat diet. Mem Inst Oswaldo Cruz. 2006;101(Suppl. 1):253–60.
- Neves RH, Alencar ACMB, Costa-Silva M, et al. Long-term feeding a high-fat diet causes histological and parasitological effects on murine schistosomiasis mansoni outcome. Exp Parasitol. 2007;115(4):324–32.
- Alencar ACMB, Neves RH, Águila MB, et al. High fat diet has a prominent effect upon the course of chronic schistosomiasis mansoni in mice. Mem Inst Oswaldo Cruz. 2009;104(4):608–13.
- da Silva Filomeno CE, Costa-Silva M, Corrêa CL, et al. The acute schistosomiasis mansoni ameliorates metabolic syndrome in the C57BL/6 mouse model. Exp Parasitol. 2020;212(2020):1–6.
- Cheever AW, Lenzi JA, Lenzi HL, et al. Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz. 2002;97(7):917–40.
- Coutinho EM, Barros AF, Barbosa A, et al. Host Nutritional Status as a Contributory Factor to the Remodeling of Schistosomal Hepatic Fibrosis. Mem Inst Oswaldo Cruz. 2003;98(7):919–25.
- Bansal D, Bhatti HS, Sehgal R. Role of cholesterol in parasitic infections. Lipids Health Dis. 2005;4:10.
- Guigas B, Molofsky AB. A worm of one’s own: How helminths modulate host adipose tissue function and metabolism. Trends Parasitol. 2015;31(9):435–41.
- Meyer F, Meyer H, Bueding E. Lipid metabolism in the parasitic and free-living flatworms, Schistosoma mansoni and Dugesia dorotocephala. Biochim Biophys Acta - Lipids Lipid Metab. 1970;210(2):257–66.
- Huang H, Yan Z, Chen Y, et al. A social contagious model of the obesity epidemic. Sci Rep. 2016; (6):37961.
- Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016; 22(7):176–85.
- Stanley RG, Jackson CL, Griffiths K, et al. Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in mice. 2009;207:131–8.
- Shen SW, Lu Y, Li F, et al. Potential long-term effects of previous schistosome infection may reduce the atherogenic index of plasma in Chinese men. Int J Parasitol. 2015;45(5):289–94.
- Chen Y, Lu J, Huang Y, et al. Association of previous schistosome infection with diabetes and metabolic syndrome: A cross-sectional study in rural China. J Clin Endocrinol Metab. 2013;98(2):283–7.
- Shen S-W, Lu Y, Li F, et al. The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men. Parasite Immunol. 2015;37(7):333–9.
- Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123(11):1939–51.
- Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397–400.
- Gallou-Kabani C, Vigé A, Gross M, et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring). 2007;15(8):1996–2005.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem. 1972;1;18(6):499–502.
- Martinez EM, Neves RH, Oliveira RMF de, et al. Características biológicas e morfológicas de cepas brasileiras de Schistosoma mansoni em Mus musculus. Rev Soc Bras Med Trop. 2003;36(5):557–64.
- Weibel ER. Stereological Methods. Vol. 1. Practical Methods for Biological Morphometry. J Microsc.1981;121(1):131–2.
- Mandarim-de-Lacerda CA. Stereological tools in biomedical research. 2003;75:469–86.
- Catta-Preta M, Mendonca LS, Fraulob-Aquino J, et al. A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies. Virchows Arch. 2011;459(5):477–85.
- Franzén LE, Ekstedt M, Kechagias S, et al Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol. 2005; 27;18(7):912–6.
- Skelly PJ, Da’dara AA, Li XH, et al. Schistosome Feeding and Regurgitation. PLoS Pathog. 2014;10(8).
- McKay DM. The beneficial helminth parasite? Parasitol. 2006 Jan 21;132(01):1–12.
- Stewart D, Fulton WB, Wilson C, et al. Genetic contribution to the septic response in a mouse model. Shock. 2002;18(4):342–7
- Wu J, Xu W, Ming Z, et al. Metabolic changes reveal the development of schistosomiasis in mice. PLoS Negl Trop Dis. 2010;4(8)e807.
- Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2012;18(19):2300–8.
- Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20(42):15539–48.
- Martins LM, Oliveira AR, Soares Cruz KJC, et al. Obesity, inflammation, and insulin resistance. Brazilian Journal of Pharmaceutical Sciences. 2014;50(4):677-692.